Biotech | May 02, 2022
CIVCO Radiotherapy to Unveil TotalRT All in One Solution at ESTRO 2022
CIVCO RT will also display its recent innovations focusing on improving patient comfort and outcomes
CIVCO RT will also display its recent innovations focusing on improving patient comfort and outcomes
The funding round is led by Kalaari Capital. Aflac Ventures, Digital Horizon, Stride Ventures, and existing investors also participated in the round
Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology
The company is Series A funded with US $ 7 million in funding so far
he financing was significantly oversubscribed with high demand from both existing and new investors.
Biosynthetic Technologies produces estolides, a new class of biobased synthetic oils used in a number of applications, including motor oil, industrial lubricants, pharmaceuticals, and personal care.
This will evaluate the immunogenicity, safety, and reactogenicity of a single booster dose in adults aged 18 years and older
First participants enrolled in clinical trial received Omicron-based vaccine candidate as a two-dose primary series and as a booster dose
Earlier last week the U.S. FDA had also shortened the time to receive a Pfizer booster shot from six months to five months for everyone 12 and older
Emergency Use Authorisation (EUA) is granted for individuals 65 years of age and older, and individuals ages 18 through 64 within certain high-risk groups
Subscribe To Our Newsletter & Stay Updated
